| Serial Number | 75774522 |
| Word Mark | PHARMAPRINT CERTIFIED NATURAL ACTIVES |
| Filing Date | Thursday, August 12, 1999 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Tuesday, August 13, 2002 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 20, 2001 |
| Disclaimer with Predetermined Text | "CERTIFIED" and "NATURAL ACTIVES" |
| Description of Mark | The mark consists in part of a stylized leaf. |
| Goods and Services | Nutritional supplements, vitamin and mineral supplements, herbal extracts, and combinations of the above; and pharmaceuticals and pharmaceutical preparations based on natural medicines that are used to treat premenstrual stress, regulate the menstrual cycle, promote the menstrual flow, reduce menstrual pain and discomfort, increase breast milk production and alter hormone amounts that cause breast milk production, cause significant diarrhea, improve wound healing and superficial wound healing, reduce skin inflammation, reduce itching, protect and reduce stress to the liver and protect against damage caused to the liver, namely, scarring, cirrhosis, inflammation and hepatitis, treat arthritis, degenerative arthritis and rheumatism, reduce diarrhea and inflammation, reduce muscle and joint pain, treat sore throat pain, cause sleepiness and treat insomnia, treat bronchitis, bronchial asthma and asthma, reduce cramping pain, reduce digestive tract distress, treat hemorrhoids, treat swelling due to insufficient blood flow in veins, varicose veins and calf cramping pain, treat inadequate blood flow in the brain, increase resistance to bacterial and virus infections, assist the treatment of recurring respiratory and urinary tract infections; reduce outbreaks of skin eczema, reduce migraine headache pain, reduce fatty substances in the blood, namely, triglycerides and cholesterol, reduce the stickiness of platelets and clotting, increase the breakdown of blood clots, reduce nausea by acting on the digestive tract, treat ringing in the ears, treat abnormal changes in the retina, increase sexual desire, treat cancer, increase life expectancy, improve heart function, treat heart conditions associated with the elderly, mild heart pain brought on by exertion, angina, and mild irregular heart beat, lower blood pressure, reduce intestinal tract distress, treat ulcers, reduce pain and inflammation; act as a free radical scavenger and antioxidant, improve urination and help the body remove excess fluid through urination, treat non-cancerous enlargements of the male prostate gland and symptoms caused by non-cancerous enlargements and other disorders of the male prostate gland, help rid the body of worms, treat diabetes, stimulate and modify the body¿s immune system and treat immunodeficiencies, assist in the treatment of aids, reduce stress caused by environmental factors and promote calm, treat mild to moderate mood depression, help protect a developing fetus against damage from exposure to drugs, chemicals and other harmful substances, stimulate hair growth, and are general tonics, namely, substances producing healthy muscular condition and reaction of organs |
| Goods and Services | Pharmaceutical manufacturing to the order and specifications of others |
| Goods and Services | Pharmaceutical research, namely, medical research in the nature of identifying and quantifying the active and effective components of natural medicines so that pharmaceutical versions can be made and tested |
| Lining/Stippling Statement | The stippling shown in the drawing page is a feature of the mark and is not intended to indicate color. The lining shown in the drawing page is a feature of the mark and is not intended to indicate color. |
| Pseudo Mark | PHARMACEUTICAL PRINT CERTIFIED NATURAL ACTIVES |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 29, 1999 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 29, 1999 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 9, 2001 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PharmaPrint Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92612 |
| Party Name | PharmaPrint Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92612 |
| Event Date | Event Description |
| Tuesday, January 7, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, August 2, 2002 | PAPER RECEIVED |
| Tuesday, February 12, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 20, 2001 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 31, 2001 | NOTICE OF PUBLICATION |
| Monday, February 5, 2001 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 7, 2000 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 7, 1999 | NON-FINAL ACTION MAILED |
| Friday, November 19, 1999 | ASSIGNED TO EXAMINER |
| Thursday, November 18, 1999 | ASSIGNED TO EXAMINER |